Nonhuman primates (NHPs) account for only 0.5% of all animals currently in preclinical research. A far higher percentage of health advances that have improved the quality of life of millions of patients, and saved millions more, were developed in part because of preclinical NHP models. Studies on NHPs are crucial when it comes to our understanding of how the human brain works, and more importantly, when it comes to our understanding of pathological processes in neurological diseases like Parkinson’s and Alzheimer’s. This also applies to the treatment and prevention of novel infectious diseases like Ebola, Covida and the Zika virus. Non-human primates are perhaps most important for the immunological similarity to humans; GLP toxicology studies see the greatest usage of NHPs in preclinical research.

NHP models have exponentially improved our understanding of many diseases, and given us a clearer insight on the best way to carry out life saving procedures like organ transplants. Our facilities at PharmaLegacy are equipped to house more than 350 NHPs for your studies, with another 30,000 Cynomolgus and Rhesus monkeys available off-site. Factor-in our unmatched experience in pharmacology, and your pipeline will be ready for IND in the blink of an eye!